The aim of this study was to investigate clinicopathologic findings in 54 cases diagnosed with atypical leiomyomas (ALs) as well as Ki-67 and p53 expressions immunohistochemically. The authors believe that the patients diagnosed with ‘AL with focal atypia-limited experience’ should be diagnosed as AL.

In a study conducted between 2012-2014, 84 breast cancer patients were examined and after surgery, tumours idetified were stained with antibody. The result revealed that breast cancer progression is often associated with alterations in expressions of Ki67, P53 and Her-2 markers.